Ceribell — Q3 2026 Earnings Summary

Ceribell reported third-quarter 2026 total revenue of $29.3 million, marking a 30% increase from the same period in 2025. The company ended the quarter with 747 active accounts and achieved a gross margin of 90%, driven by manufacturing cost reductions and a new production line in Vietnam. Operating expenses rose to $46.9 million due to investments in commercial infrastructure, research and development, and intellectual property litigation, resulting in a net loss of $21.4 million. Ceribell raised its full-year 2026 revenue guidance to a range of $115 million to $117 million and announced the full commercial launch of its delirium monitoring solution.